This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
340B Manufacturer Exclusions Summary
Updated January 25, 2024
| Manufacturer | Effective Date | CEs Affected | ESP Submissions |
|---|---|---|---|
| Eli Lilly | 9/1/2020 | All | No starting 11/16/23 – only allows 1 pharmacy designation for CP |
| AstraZeneca | 10/1/2020 | All | No |
| Novartis | 11/16/2020 | Hospitals Only | Yes – but only for 1 CP or WO pharmacy starting 5/1/2023 |
| Novo Nordisk | 1/1/2021 | Hospitals Only | No starting 6/1/2023 – only allows 1 pharmacy designation for CP or WO |
| Sanofi | 3/1/2021 | Hospitals and CHC | No starting 6/1/2023 – only allows 1 pharmacy designation for CP |
| Boehringer Ingelheim | 8/1/2021 | Hospitals and CHC | No – only allows 1 pharmacy designation for CP within 40 miles |
| Merck | 9/1/2021 | Hospitals and CHC | No starting 6/12/2023 – only allows 1 pharmacy designation for CP within 40 miles. Starting 7/31, allow pricing for all CEs in AR and LA only if submit data to ESP |
| United Therapeutics | 12/1/2021 | All | Yes |
| UCB | 12/31/2021 | Hospitals Only | No |
| Amgen | 1/3/2022 | Hospitals Only | Yes – but only for 1 CP starting 4/11/2023 within 40 miles |
| Abbvie | 2/1/2022 | Hospitals Only | Yes – but only for 1 CP within 40 miles or WO pharmacy starting 4/17/2023 |
| Bristol Myers Squibb | 3/1/2022 | All | No |
| Pfizer | 3/1/2022 | Hospitals Only | Yes – but can only pick 1 contract pharmacy starting 5/1/2023 for certain products only |
| GlaxoSmithKline | 4/1/2022 | All | No starting 5/1/23 – only allows 1 pharmacy designation for CP or WO |
| Janssen | 5/2/2022 | Hospital Only | Yes – but only for 1 CP plus WO pharmacy starting 3/7/2023 |
| Gilead | 5/2/2022 | All | Yes for WO pharmacy only. CE without in-house pharmacy can designate one CP |
| Exelixis | 7/6/2022 | Hospitals Only | Yes – but only for 1 CP starting 5/15/2023 and WO pharmacy starting 6/26/23 |
| Bausch Health | 8/1/2022 | All | No starting 6/26/23 – only allows 1 pharmacy designation for 1 CP within 40 miles |
| Biogen | 2/1/2023 | Hospitals Only | No |
| Bayer Health | 3/1/2023 | Hospital Only | No starting 6/1/23 – only allows 1 pharmacy designation for 1 CP within 40 miles |
| EMD Serono | 3/1/2023 | Hospitals Only | No – only allows 1 pharmacy designation for CP or WO |
| Organon | 7/1/2023 | Hospitals Only | No – only allows 1 pharmacy designation for CP |
| Teva | 7/5/2023 | Hospitals Only | No – only allows 1 pharmacy designation for CP within 40 miles. Starting 8/1/2023, allow pricing for all CEs in LA with no data submission requirement |
| Astellas | 9/1/2023 | Hospitals Only | No – only allows 1 pharmacy designation for CP |
| Jazz Pharmaceuticals | 10/9/2023 | Hospitals Only | No – only allows 1 pharmacy designation for CP |
| Incyte | 10/16/2023 | Hospitals Only | No – only allows 1 pharmacy designation for CP within 40 miles |
| Eisai | 11/1/2023 | Hospitals Only | No – only allows 1 pharmacy designation for CP |
| Sandoz | 12/1/2023 | Hospitals Only | Yes but only for 1 CP within 40 miles of parent site. If no CP within 40 miles, may consider 1 exception. WO pharmacy unaffected |
| Takeda | 1/22/2024 | Hospitals Only | Yes but only for 1 CP or WO pharmacy within 40 miles of parent site |